相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunotherapy for Thymic Cancers: A Convoluted Path Toward a Cherished Goal
Arun Rajan
JOURNAL OF THORACIC ONCOLOGY (2021)
Durable Response in Patients With Thymic Carcinoma Treated With Pembrolizumab After Prolonged Follow-Up
Giuseppe Giaccone et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer
Yalai Bai et al.
CLINICAL CANCER RESEARCH (2021)
CD3+, CD8+, CD4+ and FOXP3+ T Cells in the Immune Microenvironment of Small Bowel Neuroendocrine Tumors
Niko Hiltunen et al.
DISEASES (2021)
Immunotherapeutic potential of CD4 and CD8 single-positive T cells in thymic epithelial tumors
Yoko Yamamoto et al.
SCIENTIFIC REPORTS (2020)
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer
Giovanni Bocchialini et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2020)
Heat shock protein 90α in thymic epithelial tumors and non-thymomatous myasthenia gravis
Juergen Thanner et al.
ONCOIMMUNOLOGY (2020)
Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial
Jinhyun Cho et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
The clinical significance of soluble PD-1 and PD-L1 in lung cancer
Taher Abu Hejleh et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)
Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
Thomopoulou Konstantina et al.
LUNG CANCER (2019)
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study
Giuseppe Giaccone et al.
LANCET ONCOLOGY (2018)
Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer
Souptik Barua et al.
LUNG CANCER (2018)
Understanding the tumor immune microenvironment (TIME) for effective therapy
Mikhail Binnewies et al.
NATURE MEDICINE (2018)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+T-cell infiltration in stage II-III colorectal cancer
Chih-Yang Huang et al.
SCIENTIFIC REPORTS (2018)
The expanding role of radiation therapy for thymic malignancies
Jonas Willmann et al.
JOURNAL OF THORACIC DISEASE (2018)
Systemic treatments for thymoma and thymic carcinoma: A systematic review
Thierry Berghmans et al.
LUNG CANCER (2018)
Low PD-1 Expression in Cytotoxic CD8+ Tumor-Infiltrating Lymphocytes Confers an Immune-Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value
Giulia Mazzaschi et al.
CLINICAL CANCER RESEARCH (2018)
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project
Fred R. Hirsch et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Analysis of a panel of druggable gene mutations and of ALK and PD-Ll expression in a series of thymic epithelial tumors (TETs)
Marcello Tiseo et al.
LUNG CANCER (2017)
QuPath: Open source software for digital pathology image analysis
Peter Bankhead et al.
SCIENTIFIC REPORTS (2017)
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research
Shona Hendry et al.
ADVANCES IN ANATOMIC PATHOLOGY (2017)
Clinical experiences of combining immunotherapy and radiation therapy in non-small cell lung cancer: lessons from melanoma
Anusha Kalbasi et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2017)
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Peter Savas et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma
Shintaro Yokoyama et al.
ANNALS OF THORACIC SURGERY (2016)
Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma
Shintaro Yokoyama et al.
CLINICAL CANCER RESEARCH (2016)
The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer
Roy M. Bremnes et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Thymic epithelial tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
N. Girard et al.
ANNALS OF ONCOLOGY (2015)
Classifying Cancers Based on T-cell Infiltration and PD-L1
Michele W. L. Teng et al.
CANCER RESEARCH (2015)
Diffuse High Intensity PD-L1 Staining in Thymic Epithelial Tumors
Sukhmani K. Padda et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2014)
Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database
Enrico Ruffini et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2014)
The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: Proposal for an Evidence-Based Stage Classification System for the Forthcoming (8th) Edition of the TNM Classification of Malignant Tumors
Frank C. Detterbeck et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting
Alexander Marx et al.
JOURNAL OF THORACIC ONCOLOGY (2014)
Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
Stefani Spranger et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Retrospective outcomes studies for orphan diseases: challenges and opportunities
Peter Sun et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Thymic Malignancies: From Clinical Management to Targeted Therapies
Ronan J. Kelly et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
The Masaoka-Koga Stage Classification for Thymic Malignancies Clarification and Definition of Terms
Frank C. Detterbeck et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Standard Outcome Measures for Thymic Malignancies
James Huang et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Thymic epithelial turnours: A population-based study of the incidence, diagnostic procedures and therapy
Wouter K. de Jong et al.
EUROPEAN JOURNAL OF CANCER (2008)
Thymic carcinoma: 30 cases at a single institution
Motoki Yano et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism
Fabienne Venet et al.
JOURNAL OF IMMUNOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice
SE Erdman et al.
CANCER RESEARCH (2005)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
分享论文
